Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1612042 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $252.05Day −0.94%1Y +54.3%Off 52W high −10.7%Vol (1Y) 37.5%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,510 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest5.0% of sh out |
| Days to cover5.6d |
| 13F net flow (QoQ)+1.88% |
| Top-10 13F concentration65.5% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)€720.1M |
| Earnings (TTM)-€228.0M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (EUR). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+18.2% |
| 1Y+54.3% |
| 3Y+179.6% |
| 5Y+115.6% |
| Since incept. (ann.)+33.5% |
Total return through 2026-07-29 · series begins 2016-08-01. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)37.5% |
| Ann. volatility (3Y)40.6% |
| Sharpe (1Y)1.34 |
| Sharpe (3Y)1.02 |
| Max drawdown (1Y)−17.6% |
| Max drawdown (3Y)−29.2% |
| Beta (3Y vs SPY)0.55 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10.3M | $2.4B | 16.59% | +0.0% |
| T. Rowe Price Investment Management, Inc. | 6.2M | $1.4B | 9.94% | +124.2% |
| Avoro Capital Advisors LLC | 5.1M | $1.2B | 8.17% | −1.0% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4.8M | $1.1B | 7.77% | −7.2% |
| FMR LLC | 3.9M | $887M | 6.25% | −6.7% |
| Artisan Partners Limited Partnership | 3.2M | $739M | 5.21% | +0.1% |
| FRANKLIN RESOURCES INC | 2.1M | $469M | 3.31% | +7.4% |
| Capital International Investors | 2.0M | $448M | 3.16% | −36.1% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 101.1% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 2,832,689 shares (settlement 2026-04-30) accounts for the excess.
No reported quarters on file for ASND.
